4T1-hCD47

PDF 받기

Strain Information

검증 데이터

image.png

Fig1. hCD47 expression on in vitro cultured cells of 4T1-hCD47. (In collaboration with CrownBio)

image.png

Fig2. In vivo validation of 4T1-hCD47 in hSIRPA/hCD47 (BALB/c) mice. (In collaboration with CrownBio) hSIRPA/hCD47 Balb/C mice were inoculated subcutaneously with 4T1 at 3×105 and 4T1-hCD47 at 3×106 cells/mouse inoculum for tumor development.

image.png

Fig3. hCD47 expression in tumors after in vivo growth of 4T1-hCD47 in hSIRPA/hCD47(BALB/c) mice. (In collaboration with CrownBio) The tumors were collected at day 35 and day 40 post tumor cell inoculation.


Related Strain(s)

당신은 또한 좋아할 수 있습니다

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

조회
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

조회